Correction to: Trastuzumab Emtansine: A Review of Its Adjuvant Use in Residual Invasive HER2-Positive Early Breast Cancer

被引：0
|
作者：
Katherine A. Lyseng-Williamson
机构：
[1] Springer Nature,
来源：
Drugs | 2020年 / 80卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The author has alerted us to the following error.
引用
收藏
页码：2001 / 2001
相关论文
共 50 条
  • [41] Trastuzumab - A review of its use in the management of HER2-positive metastatic and early-stage breast cancer
    Plosker, GL
    Keam, SJ
    DRUGS, 2006, 66 (04) : 449 - 475
  • [42] The Effect of Adding Pertuzumab to Adjuvant Trastuzumab in Early HER2-Positive Breast Cancer
    Al-Azawi, Ahmed
    Hneua, Riyadh Abd-Alrasool
    Hameed, Rana Majeed
    Hassan, Duha Maithem
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2023, 9 (03): : 197 - 200
  • [43] Misconception on the duration of ado-trastuzumab emtansine treatment for HER2-positive early breast cancer
    Chung, Clement
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (10) : 717 - 718
  • [44] An Economic Evaluation of Adjuvant Trastuzumab Therapy in HER2-Positive Early Breast Cancer
    Chen, Wen
    Jiang, Zefei
    Shao, Zhimin
    Sun, Qiang
    Shen, Kunwei
    VALUE IN HEALTH, 2009, 12 : S82 - S84
  • [45] Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients
    Mustacchi, G.
    Puglisi, F.
    Molino, A. M.
    Crivellari, D.
    Ghiotto, C.
    Ferro, A.
    Brunello, A.
    Saracchini, S.
    Turazza, M.
    Cretella, E.
    Iop, A.
    Malagoli, M.
    Stefani, M.
    FUTURE ONCOLOGY, 2015, 11 (10) : 1493 - 1500
  • [46] Use of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
    Elkerm, Y.
    Ali, I. M.
    Elsaid, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer Single-center Preliminary Results
    Zolcsak, Zita
    Loirat, Delphine
    Fourquet, Alain
    Kirova, Youlia M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (12): : 895 - 901
  • [48] Ado-Trastuzumab Emtansine (Kadcyla) for HER2-Positive Metastatic Breast Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1425): : 75 - 76
  • [49] Trastuzumab use at relapse after adjuvant trastuzumab therapy in HER2-positive breast cancer.
    Lang, I.
    Bell, R.
    Feng, F.
    Lopez, R. I.
    Jassem, J.
    Semiglazov, V.
    Al-Sakaff, N.
    Carreras, E.
    Chang, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] Trastuzumab emtansine in HER2-positive metastatic breast cancer: what is the best sequence?
    Ricci, Francesco
    Le Tourneau, Christophe
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (01)
12345